prof. RNDr. Lenka Zdražilová Dubská, Ph.D.
Department head, Department of Laboratory Medicine
office: bldg. C03/333
Kamenice 753/5
625 00 Brno
| phone: | +420 549 49 8238 |
|---|---|
| e‑mail: |
| social and academic networks: |
|---|
Total number of publications: 125
2018
-
Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatment
Cancer Immunology and Immunotherapy, year: 2018, volume: 67, edition: 12, DOI
2017
-
Adjustment of serum HE4 to reduced glomerular filtration and its use in biomarker-based prediction of deep myometrial invasion in endometrial cancer
Oncotarget, year: 2017, volume: 8, edition: 64, DOI
-
Immunomonitoring of patients treated with personalized dendritic cell-based vaccine
Year: 2017, type: Conference abstract
-
Je možné pozorovat etnickou diferenci v základních krevních testech? Údaje z programu onkologické prevence v komplexním onkologickém centru v České republice
Klinická onkologie, year: 2017, volume: 2017, edition: 30(Supplementum1)
2016
-
18PTKI pazopanib impaires immunostimulatory properties of monocytes: Implication for monocyte-derived DC-based anti-cancer vaccine preparation
Year: 2016, type: Conference abstract
-
'Candidatus Rickettsia mendelii', a novel basal group rickettsia detected in Ixodes ricinus ticks in the Czech Republic
Ticks and Tick-borne Diseases, year: 2016, volume: 7, edition: 3, DOI
-
Laboratorní diagnostika v onkologii 2016. Sborník edukativních příspěvků stejnojmenné konference pořádané Masarykovým onkologickým ústavem a Lékařskou fakultou Masarykovy univerzity pod záštitou České asociace sester
Year: 2016, type: Editing of thematic compilation, editing of monothematic issue of profesional journal
-
The Safety of Therapeutic Monoclonal Antibodies: Implications for Cancer Therapy Including Immuno-Checkpoint Inhibitors
Physiological Research, year: 2016, volume: 65, edition: Suppl. 4
2015
-
B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia
Biomed Research International, year: 2015, volume: 2015, edition: "792187", DOI
-
Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical view
BMC Gastroenterology, year: 2015, volume: 15, edition: MAR 24 2015, DOI